BBIO vs VMC · rev $221.9M vs P/E 35, rev $7.42B
BridgeBio Pharma Inc (BBIO) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
BBIO currently screens at market cap $13.24B. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the BBIO and VMC stock pages for the full models.
Not investment advice.